- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06633393
Effect of a Myopia Prediction System on Myopia Prevention and Control
Impact of Feedback Based on the Myopia Prediction System on High Myopia Risk and Consultation Behavior in School-aged Children: a Cluster Randomized Controlled Trial
The global rise in myopia, particularly among children and adolescents in China, underscores the inadequacy of current prevention strategies, indicating that conventional screening and education alone are insufficient to curb the prevalence. Integrating personalized myopia prediction into routine care may enhance risk awareness, promote proactive prevention, and improve adherence to medical advice, ultimately reducing the future burden of high myopia.
A myopia prediction system based on artificial intelligence was previously developed, accurately predicting future high myopia risk using efficient, robust, and easily accessible predictive factors, including age, spherical equivalent, and the annual progression of spherical equivalent. This study aims to conduct a prospective, one-year, cluster randomized controlled clinical trial to investigate the effectiveness of this prediction system in preventing and controlling myopia in school-aged children.
Study Overview
Status
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yahan Yang, M.D., Ph.D
- Phone Number: +86 15521013933
- Email: yah.yang39@qq.com
Study Contact Backup
- Name: Xinwei Chen, M.D.
- Phone Number: +86 13535382011
- Email: cxw20000709@163.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China
- Zhongshan Ophthalmic Center, Sun Yat-sen University
-
Contact:
- Haotian Lin, M.D., Ph.D
- Phone Number: +86 13802793086
- Email: linht5@mail.sysu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The participant and their guardian voluntarily signed the informed consent form
- Has the record of eye refraction examination in the past year
- Aged 9 to 11 years, regardless of gender
Exclusion Criteria:
- High myopia(spherical equivalent ≤ -6.00 D)
- Ocular diseases other than myopia (e.g., strabismus, amblyopia, congenital cataract, juvenile glaucoma, retinal diseases).
- Systemic diseases that may affect vision or visual development (e.g., diabetes or other endocrine disorders, cardiovascular or respiratory diseases, Down syndrome)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Arm
At baseline and six months, feedback on ophthalmic examination results and future high myopia risk at 18 years of age using the myopia prediction system
|
At baseline and six months, participants will be provided with the results of their predicted risk of high myopia at age 18 based on the myopia prediction system.
At baseline and six months, participants will be provided with the results of their ophthalmic examinations.
|
|
Active Comparator: Control Arm
At baseline and six months, feedback on ophthalmic examination results.
|
At baseline and six months, participants will be provided with the results of their ophthalmic examinations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Individuals Predicted to Develop High Myopia at Age 18 by the Myopia Prediction System
Time Frame: 1 year
|
At the end of the one-year study, the Myopia Prediction System will be used to predict whether students will develop high myopia at age 18 in both the intervention and control groups.
The Proportion of Individuals Predicted to Develop High Myopia at Age 18 by the Myopia Prediction System is calculated as the total number of students in each group predicted to develop high myopia by age 18, divided by the total number of students in the respective group.
|
1 year
|
|
Cumulative Clinical Visit Rate for Myopia Prevention and Control
Time Frame: Within 3 months after each intervention
|
The Cumulative Clinical Visit Rate Proportion of Clinical Visits for Myopia Prevention and Control is the proportion of students in the intervention or control group who visited a hospital or clinic for myopia-related care (e.g., refractive exams and treatment) at least once within three months of either intervention.
It is calculated as the number of students in each group who attended a clinical visit within three months of at least one intervention, divided by the total number of students in the respective group.
|
Within 3 months after each intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Myopia Incidence Rate
Time Frame: 1 year
|
1-year myopia incidence rate = number of new myopia cases within one year / number of non-myopic cases at baseline * 100%
|
1 year
|
|
Changes in Spherical Equivalent
Time Frame: 1 year
|
Change in spherical equivalent (non-cycloplegic autorefraction) will be calculated
|
1 year
|
|
Screen Time
Time Frame: 1 year
|
Daily usage time of electronic devices (computer/smartphone/tablet computer) will be calculated
|
1 year
|
|
Outdoor Activity Time
Time Frame: 1 year
|
Daily outdoor activity time will be calculated
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Haotian Lin, M.D., Ph.D, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024KYPJ102
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Feedback on Predicted High Myopia Risk at Age 18 Using the Myopia Prediction System
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted